Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Influenza

Flu vaccination coverage has been declining in Europe, WHO report reveals

The research also found that half of European countries reported a decrease in the number of vaccines available.

Vaccination

Source: Shutterstock.com

Research by the European Centre for Disease Prevention and Control and the World Health Organization’s Regional Office for Europe reported that decreasing numbers of flu vaccinations in European countries compromised the ability of the countries to deal with annual epidemics of influenza

Seasonal flu vaccination coverage among high-risk groups has fallen in Europe, and just one European country reached the recommended goal of 75% coverage in older people, a study has found.

The research published in Vaccine[1], which looked at information from surveys of seasonal influenza vaccine recommendations; number of vaccines distributed; and vaccination coverage by target groups between 2008–2009 and 2014–2015, also found that half of European countries reported a decrease in the number of vaccines available.

Produced by the European Centre for Disease Prevention and Control and the World Health Organization (WHO) Regional Office for Europe, the study found that less than one third of older people were vaccinated in half of the countries surveyed and only one country reached the recommended goal of 75% coverage in older people in 2014–2015.

In a joint statement, published on 7 February 2018, the two organisations warned that the low uptake of seasonal influenza vaccination in Europe jeopardised the capacity to protect people during annual epidemics.

“Vaccination is the most effective measure to prevent severe disease caused by influenza. However, according to our research, influenza vaccination uptake has been steadily declining in a number of countries in the European Region,” said Zsuzsanna Jakab, WHO regional director for Europe.

“This is of serious concern now for people at higher risk of severe consequences, especially older people, and in the future potentially for the entire population, as the production of pandemic vaccines is closely linked to seasonal vaccine use.

“I urge European countries to increase vaccination coverage to hit the goal of 75% uptake among older and other at-risk people,” she added.

The WHO and partners have estimated that more than 44,000 people die annually of respiratory diseases associated with seasonal influenza in the WHO European Region. Despite the fact that over 75% of these deaths are among people aged 65 years or above, vaccine uptake remains low in this group.

Accessibility, availability and convenience of vaccination services; social and cultural norms; and individual motivation, knowledge and skills have all been identified by the WHO as barriers to vaccination.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204375

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Vaccination

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.